ASSESSMENT OF THE PSYCHOEMOTIONAL COMPONENTS OF PHARMACOTHERAPY PATIENTS SUFFERING WITH HYPERTENSION DISEASE
PDF
DOI

How to Cite

Nurillaeva N.M, Qahharova Sh.B., & Adilova N.A. (2023). ASSESSMENT OF THE PSYCHOEMOTIONAL COMPONENTS OF PHARMACOTHERAPY PATIENTS SUFFERING WITH HYPERTENSION DISEASE. Journal of Universal Science Research, 1(11), 672–676. Retrieved from https://universalpublishings.com/index.php/jusr/article/view/2943

Abstract

In the last decade, among medical scientists and doctors all over the world, the interest in the problems of patients' commitment to the treatment process is increasing, which is explained by the fact that the effectiveness of the treatment of most common chronic diseases is directly related not only to adequate treatment, but also to the level of patients' adherence to the treatment process. Among the developed countries, according to the results of epidemiological studies conducted in our Republic, the prevalence rate of arterial hypertension (AG) among the population ranges from 20 to 40%, and taking into account the fact that this rate increases with age, it is necessary to improve the effectiveness of hypotensive treatment and support patients with hypertension. relevance arises. [5, ]. Research shows that only about 50% of patients with cardiovascular disease follow the doctor's instructions [6]. It should be noted that a high level of adherence has a positive effect on the quality of life of patients and the course of the disease [7].

PDF
DOI

References

Danilov, D.S. Complaens v meditsine i metody ego optimizatsii (clinical, psychological and psychotherapeutic aspects) [Text]/ D.S. Danilov //Psychiatry and psychopharmacotherapy. - 2008. - T. 10 - No. 1 - S. 13–20.

Kadyrov R. V., Asriyan O. B., Kovalchuk S. A. Questionnaire "uroven komplaentnosti" / Monograph. Vladivostok.-2014. 23s.

Lapin I.P. Lichnost i lekarstva. Introduction to psychology and pharmacotherapy, Dean, SPb, 2001, 414p.

Nurillaeva N.M. Osobennosti diagnostiki anxiety-depressive condition in heart-vascular system diseases. Tashkent, 2011. S. 3-12.

Pereira V, Lunet N, Azevedo A. et al. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens. 2009; 27:963-975.

Stewart K, George J, McNamara KP. et al. A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial). J Clin Pharm Ther. 2014; 39 (5):527-34.

Simpson SH, Eurich DT, Majumdar SR. et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006; 333:15-20.

Krousel-Wood M, Thomas S, Munter P. et al. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004; 19 (4):357-362.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.